2023 AAFP CME Symposium - Optimizing Outcomes in Patients with Hyperkalemia: Exploring the Role of the Family Physician

HAZLET, N.J. - EntSun -- In this program, experts will discuss the risk factors for, and risks of hyperkalemia, treatment goals of  acute and chronic hyperkalemia, the importance of RAASi in CKD and HF patients, the potential adverse outcomes in individuals with ESRD undergoing adequate hemodialysis with predialysis hyperkalemia,  and evidence with K+ binders in various patient populations. A multi-specialty faculty, consisting of two nephrologists, a dietician, and a primary care physician, will then discuss cardiorenal challenges faced by family physicians, including dietary recommendations to their patients with hyperkalemia. In addition, the panel will identify key cardiorenal messages for patients taking K+ binders (for hyperkalemia) and sodium-glucose cotransporter 2 (SGLT2) inhibitors which reduce the risk for hyperkalemia and significantly improve cardiorenal outcomes.

More on EntSun News

• The Five Pillars of Success Pillar One Strengths Outlined by Rosann Santos CPC
• Pitch Black Appoints New Chief People Officer
• Blood On The Saddle To Headline X-Mess Sessions
• Emmy Award Winning Journalist Joins Prominent Haddonfield Real Estate Agency
• Steven Gary Spreads Holiday Cheer with Album release "Tis the Season"

Click here for more information

CHAIR

Csaba P. Kovesdy, MD
Fred Hatch Professor of Medicine
Director, Clinical Outcomes and Clinical Trials Program in Nephrology
University of Tennessee Health Science Center
Memphis VA Medical Center
Memphis, Tennessee

FACULTY

Deborah Clegg, PhD
Vice President for Research
Texas Tech University Health Sciences Center El Paso
Professor of Internal Medicine
Paul L. Foster School of Medicine El Paso, Texas

Jay Shubrook, DO
Professor, Primary Care Department
Touro University California College of Osteopathic Medicine
Vallejo, California

Bruce Spinowitz, MD
Associate Director, Nephrology
Vice Chairman, Medicine
New York-Presbyterian Queens
Professor of Clinical Medicine
Weill Cornell Medical College
New York, New York

This educational activity is intended for primary care physicians and other clinicians managing patients at risk for, and with hyperkalemia.

More on EntSun News

• Founder Brings Inaugural Event To Braselton Georgia At Legendary Resort and Winery
• HBCUs Among Groups Heading to The Bahamas for Track & Field Competition in March 2024
• Noble World Foundation Proposes UN Security Council Reform to Foster Global Peace
• Civil War Mockumentary BULLETS OVER ANTEBELLUM Wraps Production with a Star-Studded Cast
• India Fest 2024 on Jan 27, 2024 at KY Expo Center

Voxmedia LLC gratefully acknowledges the educational grant provided by AstraZeneca Pharmaceuticals.

Voxmedia LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse practitioners may participate in this educational activity and earn a certifi cate of completion as AANP accepts AMA PRA Category 1.5 Credits™ through its reciprocity agreements.

Pre-registration is for planning purposes only and does not guarantee seating. For additional CME/CE activities visit www.CMEPlanet.com #AAFPFMX #hyperkalemia #physician #potassium #cardiorenal #diet